Encore PFO Closure Device - The PerFOrm Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

Also called NCT05537753

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05537753
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05537753. Randomized; no masking; primary purpose treatment. Start 2023-07-12 (actual); primary completion 2026-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Encore PFO Closure Device - The PerFOrm Trial
Condition
Patent Foramen Ovale
Condition
Cryptogenic Stroke
Intervention (Device)
Encore PFO closure device
Intervention (Device)
FDA-approved PFO closure device
Lead sponsor
Encore Medical Inc. (class: industry)
Collaborator
Bright Research Partners (class: industry)
Collaborator
Yale Cardiovascular Research Group (class: other)

Record details

Record id
cardio:ct-nct05537753
Content hash
54f9a15a5e60f55632e420360e8d701c3d87d46ff80a3c54040ac6f27e8f8d75